Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer

R. L. Coleman*, G. F. Fleming, M. F. Brady, E. M. Swisher, K. D. Steffensen, M. Friedlander, A. Okamoto, K. N. Moore, N. Efrat Ben-Baruch, T. L. Werner, N. G. Cloven, A. Oaknin, P. A. DiSilvestro, M. A. Morgan, J. H. Nam, C. A. Leath, S. Nicum, A. R. Hagemann, R. D. Littell, D. CellaS. Baron-Hay, J. Garcia-Donas, M. Mizuno, K. Bell-McGuinn, D. M. Sullivan, B. A. Bach, S. Bhattacharya, C. K. Ratajczak, P. J. Ansell, M. H. Dinh, C. Aghajanian, M. A. Bookman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

608 Scopus citations

Fingerprint

Dive into the research topics of 'Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science